MENU
+Compare
SIGGF
Stock ticker: OTC
AS OF
Sep 25 closing price
Price
$1.98
Change
-$0.01 (-0.50%)
Capitalization
22.72B

SIGGF stock forecast, quote, news & analysis

Sigma Healthcare is Australia’s largest retail pharmacy franchisor, most notably owning the Chemist Warehouse brand, which it merged with in 2025... Show more

SIGGF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for SIGGF with price predictions
Sep 26, 2025

SIGGF sees MACD Histogram just turned negative

SIGGF saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on September 24, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 7 instances where the indicator turned negative. In of the 7 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for SIGGF moved out of overbought territory on September 22, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 5 similar instances where the indicator moved out of overbought territory. In of the 5 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

SIGGF broke above its upper Bollinger Band on September 19, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SIGGF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.402) is normal, around the industry mean (9.737). P/E Ratio (58.949) is within average values for comparable stocks, (28.788). SIGGF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.527). Dividend Yield (0.006) settles around the average of (0.031) among similar stocks. P/S Ratio (5.249) is also within normal values, averaging (141.860).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SIGGF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are McKesson Corp (NYSE:MCK).

Industry description

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

Market Cap

The average market capitalization across the Medical Distributors Industry is 10.68B. The market cap for tickers in the group ranges from 557.05K to 94.6B. MCK holds the highest valuation in this group at 94.6B. The lowest valued company is CNBI at 557.05K.

High and low price notable news

The average weekly price growth across all stocks in the Medical Distributors Industry was 1%. For the same Industry, the average monthly price growth was 3%, and the average quarterly price growth was 3%. EMPG experienced the highest price growth at 29%, while AMFPF experienced the biggest fall at -12%.

Volume

The average weekly volume growth across all stocks in the Medical Distributors Industry was -78%. For the same stocks of the Industry, the average monthly volume growth was -18% and the average quarterly volume growth was 9%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 53
Price Growth Rating: 56
SMR Rating: 84
Profit Risk Rating: 84
Seasonality Score: -4 (-100 ... +100)
View a ticker or compare two or three
SIGGF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry MedicalDistributors

Profile
Fundamentals
Details
Industry
N/A
Address
2125 Dandenong Road
Phone
+61 392159215
Employees
156
Web
https://www.sigmahealthcare.com.au